Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS) SHH

Currency In CNY

AD

Valuation

Market Cap8.39B
Enterprise Value9.68B
P/E Ratio-3.19
PEG Ratio0.01
Price/Sales Ratio16.41
Price/Book Ratio0.81
Enterprise/Revenue22.75
Enterprise/EBITDA-4.15

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin-5.15
Operating Margin-2.86
AD

Management Effectiveness

Return On Assets-0.15
Return On Equity-0.24

Income Statement

Revenue798.06M
Revenue/Share0.3
Gross Profit-22.06M
EBITDA-1.31B
Net Income-1.37B
Diluted EPS-1.45

Balance Sheet

Total Cash60.35M
Total Cash/Share0.06
Total Debt1.88B
Total Debt/Equity0.32
Current Ratio1.16
Book Value Per Share6.21

Price History

52-Week Change-56.9
52-Week High11.9
52-Week Low4.21
Moving Average 50 Days5.17
Moving Average 200 Days6.33

Statistics

Average Volume29.7M
Shares Outstanding940.24M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.07
Last Split Factor2:1
Last Split DateJune 13, 2016
AD